
Dr Chatterjee Kishore is the Head of Oncology Development and Board of Directors at Astellas. She has a PhD in Medical Genetics, followed by an MBA with more than 25 years in the industry sector, driving innovation to change the course of cancer treatment for patients across geographies. She is committed to accelerating the development of transformational oncology therapies that improve survival, quality of life, and equity of access for cancer patients, while generating the evidence needed to demonstrate value to regulators, payers, healthcare systems, and patients.
Updated: August 2026